What does the clinician need to improve patient care in systemic sclerosis?

Annals of the Rheumatic Diseases

Volumn 66, Issue 9, 2007, Pages 1129-1131

  Vonk, Madelon C ^a   Van Den Hoogen, Frank H J ^b   Van Riel, Piet L C M ^a   Valentini, Gabriele ^c  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b SINT MAARTENSKLINIEK   (Netherlands)

^c SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

DIAGNOSTIC TEST; DISEASE ACTIVITY; DISEASE CLASSIFICATION; DISEASE SEVERITY; EDITORIAL; HUMAN; PATIENT CARE; PHYSICIAN; PRIORITY JOURNAL; SCLERODERMA; SYSTEMIC SCLEROSIS;

ACUTE DISEASE; HEALTH STATUS INDICATORS; HUMANS; PATIENT CARE; PROGNOSIS; SCLERODERMA, SYSTEMIC; SKIN;

EID: 34548187426     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.2007.073957     Document Type: Editorial

References (17)

1. Furst DE, Clements PJ. Hypothesis for the pathogenesis of systemic sclerosis. J Rheumatol 1997;24:53-7.
2. Leroy EC, Black C, Fleischmajer R, Jablonska S, Krieg T, Medsger TA, et al. Scleroderma (systemic-sclerosis): classification, subsets and pathogenesis. J Rheumatol 1988;15:202-5.
3. Subcommittee for Scleroderma Criteria of the American Rheumatism Association diagnostic and therapeutic committee. Preliminary Criteria for the Classification of Systemic-Sclerosis (Scleroderma). Arthritis Rheum 1980;23:581-90.
4. Medsger TA, Silman AJ, Steen VD, Black CM, Akesson A, Bacon PA, et al. A disease severity scale for systemic sclerosis: development and testing. J Rheumatol 1999;26:2159-67.
5. Medsger TA, Bombardieri S, Czirjak L, Scorza R, Della Rossa A, Bencivelli W. Assessment of disease severity and prognosis. Clin Exp Rheumatol 2003;21:S42-6.
6. Valentini G, Della Rossa A, Bombardieri S, Bencivelli W, Silman AJ, D'Angelo S, et al. European multicentre study to define disease activity criteria for systemic sclerosis. II. Identification of disease activity variables and development of preliminary activity indexes. Ann Rheum Dis 2001;60:592-8.
7. Valentini G, Silman AJ, Veale D. Assessment of disease activity. Clin Exp Rheumatol 2003;21:S39-41.
8. Lonzetti LS, Joyal F, Raynauld JP, Roussin A, Goulet JR, Rich E, et al. Updating the American College of Rheumatology preliminary classification criteria for systemic sclerosis: addition of severe nailfold capillaroscopy abnormalities markedly increases the sensitivity for limited scleroderma. Arthritis Rheum 2001;44:735-6.
9. Scussel-Lonzetti L, Joyal F, Raynauld JP, Roussin A, Rich E, Goulet JR, et al. Predicting mortality in systemic sclerosis: analysis of a cohort of 309 French Canadian patients with emphasis on features at diagnosis as predictive factors for survival. Medicine 2002;81:154-67.
10. Leroy EC, Medsger TA. Criteria for the classification of early systemic sclerosis. J Rheumatol 2001;28:1573-6.
11. Barnett AJ, Miller MH, Lirrlejohn GO. A survival study of patients with scleroderma diagnosed over 30 years (1953-1983): the value of a simple cutaneous classification in the early stages of the disease. J Rheumatol 1988;15:276-83.
12. Valentini G, Ferri C. Scleroderma subsetting. Curr Rheumatol Rev 2006;2:83-7.
13. Clements PJ. Measuring disease activity and severity in scleroderma. Curr Opin Rheumatol 1995;7:517-21.
14. Furst D, Khanna D, Matucci-Cerinic M, Clements P, Steen V, Pope J, et al. Systemic sclerosis: continuing progress in developing clinical measures of response. J Rheumatol 2007,34:1194-200.
15. Della Rossa A, Valentini G, Bombardieri S, Bencivelli W, Silman AJ, D'Angelo S, et al. European multicentre study to define disease activity criteria for systemic sclerosis. I. Clinical and epidemiological features of 290 patients from 19 centres. Ann Rheum Dis 2001;60:585-91.
16. Valentini G, Bencivelli W, Bombardieri S, D'Angelo S, Delia Rossa A, Silman AJ, et al. European Scleroderma Study Group to define disease activity criteria for systemic sclerosis. III. Assessment of the construct validity of the preliminary activity criteria. Ann Rheum Dis 2003;62:901-3.
17. Valentini G, Medsger TA, Silman AJ, Bombardieri S. Conclusion and identification of the core set of variables to be used in clinical investigations. Clin Exp Rheumatol 2003;21:S47-8.